Biophore India Pharmaceuticals
Biophore India Pharmaceuticals is a peptide manufacturer based in India (Hyderabad). Direct manufacturer. Holds US DMFs for cetrorelix, icatibant, sincalide API.
Listing reviewed October 2026.
About Biophore India Pharmaceuticals
Hyderabad-based developer and manufacturer of niche APIs for generic drug makers, with peptides, oncology, contrast agents and injectable APIs among its product areas. Its Visakhapatnam site was classed NAI at its 2024 FDA inspection. Holds active US Drug Master Files for cetrorelix, icatibant and sincalide API.
Directory assessment: Biophore India Pharmaceuticals is listed as a manufacturer in the peptide supply chain, serving Asia markets from India (Hyderabad). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 3 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.
- Cetrorelix: DMF 34752 (Type II, active), submitted 2020-05-03
- Icatibant: DMF 30526 (Type II, active), submitted 2016-09-27
- Sincalide: DMF 34202 (Type II, active), submitted 2019-12-17
DMF numbers from the FDA quarterly DMF list. A filed DMF is not FDA approval; its contents are confidential. Reviewed 2026-10-23.